Moreover, CLN7 gene variants have been identified in ALS/FTD and macular degeneration implying CLN7-associated intracellular functions that could represent common and convergent therapeutic targets for neurodegeneration. This evidence concerns the gene MFSD8 and frontotemporal dementia.